FeesSafety
Pluang+

Kanzhun Limited director Haiyang Yu resigns due to other commitments, effective Oct 23, 2026.

Market News
23 Oct 2026
GlobeNewsWire
View Source
Neutral
Kanzhun Limited director Haiyang Yu resigns due to other commitments, effective Oct 23, 2026.

Kanzhun Limited, a leading online recruitment platform in China, announced that Mr. Haiyang Yu has resigned from his position as a non-executive director due to other business commitments, effective October 23, 2026. The company expressed gratitude for his contributions during his tenure. This change may impact the company's board dynamics but does not affect its ongoing operations or growth plans. Kanzhun continues to focus on expanding its recruitment platform BOSS Zhipin in China.

Kanzhun Limited's board change is noted here alongside Pluang's Technology sector market snapshot as of Oct 23, 2026 19:02 WIB. Of 150 priced Technology-sector US stocks tradable on Pluang, 40 rose and 99 fell today. Notable movers include WDC at USD 342.41 with a 1-day change of -3.33%, VNET at USD 3.91 rising 3.17%, and ACN at USD 251.86 down 2.66%. The most notable figure is the 99 stocks that declined in price.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
27 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App